Registered entities
Xanodyne Pharmaceuticals, Inc.
Reg. No. 611369774United States
Innovation
14 patent families (2 granted) — focus: Human necessities; filing pace dormant. Cited 682 times.
Investor mix
11 investors on record; lead investors include AIG Investments, Aisling Capital, Blue Chip Venture, Healthcare Ventures; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 18% |
| Private equity | 3 | 27% |
| Other / undisclosed | 6 | 55% |